Pharma Research Data Protection Agent

This leads to:

• Delayed detection of data exfiltration attempts
• Limited visibility across research and laboratory environments
• Difficulty protecting clinical trial data and intellectual property
• Increased investigation effort and response delays
• Manual enforcement of DLP and security policies
• Risk of unauthorized access to sensitive research assets
• Limited auditability of security response decisions

As pharmaceutical research becomes increasingly collaborative and cloud-enabled, organizations require autonomous security operations capable of protecting research assets while maintaining strict governance and regulatory compliance.

**Our Solution: Pharma Research Data Protection Agent (ElixirClaw)**

ElixirClaw (Agentic OS) provides a governed autonomous execution layer for protecting pharmaceutical research environments.

The platform continuously monitors laboratory systems, clinical trial repositories, collaboration platforms, identity services, user activity, and security telemetry to identify threats and orchestrate response workflows in real time.

It integrates with:

• Clinical trial management systems
• Laboratory Information Management Systems (LIMS)
• Electronic Lab Notebooks (ELN)
• Identity and access management platforms
• Collaboration and document management systems
• Security operations and SIEM platforms

The platform:

• Detects data exfiltration attempts and unauthorized access
• Identifies insider threats and anomalous user behavior
• Enforces Data Loss Prevention (DLP) policies automatically
• Initiates investigation and evidence preservation workflows
• Escalates access revocation and regulatory notifications for mandatory human approval
• Maintains complete policy traceability and audit logs
• Coordinates governed security response across research environments

This enables:

• Faster detection of research security threats
• Automated and governed protection of intellectual property
• Reduced operational risk from data breaches
• Improved coordination between security and research teams
• Continuous monitoring and operational intelligence

Unlike traditional DLP and security monitoring tools, ElixirClaw transforms fragmented security signals into **contextual, decision-driven, and executable intelligence**.

**Key Benefits:**

• Protects clinical trial data and research intellectual property
• Detects data exfiltration and insider threats faster
• Automates governed DLP and investigation workflows
• Accelerates incident response and forensic readiness
• Strengthens FDA 21 CFR Part 11 security governance
• Improves collaboration between research and security teams
• Provides complete auditability and policy traceability
• Reduces manual security operations

**Professional Services Scope:**

We provide end-to-end services including:

• **Assessment & Discovery**
• Analysis of research security operations and data protection workflows
• Evaluation of LIMS, ELN, clinical platforms, identity systems, and DLP controls
• Identification of security, compliance, and governance gaps
• **Implementation & Integration**
• Deployment of ElixirClaw on AWS
• Integration with research platforms, identity services, collaboration tools, and SIEM solutions
• Configuration of DLP policies, investigation workflows, approval gates, and governance controls
• Setup of audit trails and regulatory reporting processes
• **Managed Services**
• Continuous security monitoring and optimization
• Investigation workflow tuning and policy refinement
• Performance monitoring and operational improvements
• Cost optimization and scalability management

**Ideal Customers:**

• Pharmaceutical Manufacturers
• Biotechnology Companies
• Clinical Research Organizations (CROs)
• Drug Discovery Organizations
• Life Sciences Research Institutes

**Buyer Personas:**

• Chief Information Security Officer (CISO)
• VP Research IT Security
• Research Security Teams
• Clinical IT & Compliance Leaders
• Pharmaceutical Risk & Governance Teams